Cuba successfully developed a lung cancer vaccine
Cuba Molecular Immunology Center (CIM) announced on December 31 that it has successfully prepared a new vaccine to prevent lung cancer.
Cuba Molecular Immunology Center (CIM) announced on December 31 that it has successfully prepared a new vaccine to prevent lung cancer.
>>>Cuba tested prostate cancer vaccine
According to CIM researcher Ana Maria Vazquez (Ana Maria Vazquez), the vaccine, called Racotumomab , has been clinically tested throughout the year and demonstrates the ability of cancer patients to increase survival rates, as well. as shown by the safety and tolerance of drugs.
This new vaccine helps fight lung carcinoma by promoting the destruction of cancer cells and limiting the appearance of tumors.
Racotumomab is the second vaccine line developed by CIM to prevent lung cancer, after the CIMAvax EGF series has been proven effective in treating cancer patients in Cuba.
Lung cancer is the second most common cancer in Cuba with about 5,000 cases in the pre-existing stage of the disease.
- As a poor country, Cuba owns technology to the United States
- Cuba sells cancer medicines from green scorpion venom
- Brother: Testing for lung cancer vaccine
- Cuba expands clinical trial of vaccine against prostate cancer
- Cuba will test anti-AIDS vaccines on people
- Promising breakthrough in research on cancer treatment vaccine
- Successfully tested anti-cancer vaccine - 12 people cured
- The new cancer vaccine has just been injected into the first patient in the United States
- Lung cancer and stages
- How will Cuba's extraordinary medical qualification help America?
Belarus approves Cuban lung cancer vaccine He developed the world's first lung cancer vaccine How will Cuba's extraordinary medical qualification help America? Treatment of lung cancer by inhaler Japan identifies genes that cause lung cancer Diagnose cancer through breath The rate of British women with high lung cancer due to smoking Dogs have the ability to detect ... lung cancer